<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hodakoski C</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>155-60</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3890808</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>111(1)</volume><pubmed_abstract>Insulin activation of phosphoinositide 3-kinase (PI3K) signaling regulates glucose homeostasis through the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3). The dual-specificity phosphatase and tensin homolog deleted on chromosome 10 (PTEN) blocks PI3K signaling by dephosphorylating PIP3, and is inhibited through its interaction with phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 (P-REX2). The mechanism of inhibition and its physiological significance are not known. Here, we report that P-REX2 interacts with PTEN via two interfaces. The pleckstrin homology (PH) domain of P-REX2 inhibits PTEN by interacting with the catalytic region of PTEN, and the inositol polyphosphate 4-phosphatase domain of P-REX2 provides high-affinity binding to the postsynaptic densi</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis.</pubmed_title><pmcid>PMC3890808</pmcid><funding_grant_id>T32 CA009503</funding_grant_id><funding_grant_id>GM008224-20</funding_grant_id><funding_grant_id>R01 CA155117</funding_grant_id><funding_grant_id>UL1 TR000117</funding_grant_id><funding_grant_id>S06 GM008224</funding_grant_id><funding_grant_id>T32 CA009503-22</funding_grant_id><funding_grant_id>R01 DK71349</funding_grant_id><funding_grant_id>BBS/E/B/000C0415</funding_grant_id><funding_grant_id>R01 CA082783</funding_grant_id><funding_grant_id>R01 DK071349</funding_grant_id><funding_grant_id>BBS/E/B/000C0413</funding_grant_id><pubmed_authors>Hopkins BD</pubmed_authors><pubmed_authors>Mense SM</pubmed_authors><pubmed_authors>Keniry M</pubmed_authors><pubmed_authors>Anderson KE</pubmed_authors><pubmed_authors>Barrows D</pubmed_authors><pubmed_authors>Parsons R</pubmed_authors><pubmed_authors>Stephens LR</pubmed_authors><pubmed_authors>Kern PA</pubmed_authors><pubmed_authors>Hodakoski C</pubmed_authors><pubmed_authors>Hawkins PT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis.</name><description>Insulin activation of phosphoinositide 3-kinase (PI3K) signaling regulates glucose homeostasis through the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3). The dual-specificity phosphatase and tensin homolog deleted on chromosome 10 (PTEN) blocks PI3K signaling by dephosphorylating PIP3, and is inhibited through its interaction with phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 (P-REX2). The mechanism of inhibition and its physiological significance are not known. Here, we report that P-REX2 interacts with PTEN via two interfaces. The pleckstrin homology (PH) domain of P-REX2 inhibits PTEN by interacting with the catalytic region of PTEN, and the inositol polyphosphate 4-phosphatase domain of P-REX2 provides high-affinity binding to the postsynaptic densi</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Jan</publication><modification>2026-04-15T11:16:07.865Z</modification><creation>2026-04-07T13:56:01.626Z</creation></dates><accession>S-EPMC3890808</accession><cross_references><pubmed>24367090</pubmed><doi>10.1073/pnas.1213773111</doi></cross_references></HashMap>